{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:02:29Z","timestamp":1790262149186,"version":"4.1.0"},"reference-count":135,"publisher":"Bentham Science Publishers Ltd.","issue":"38","funder":[{"name":"National Fellowship of Schedule Tribe (NFST), Ministry of Tribal Affairs, Government of India","award":["215262601"],"award-info":[{"award-number":["215262601"]}]},{"name":"Host University","award":["202122-NFST-ODI-01133"],"award-info":[{"award-number":["202122-NFST-ODI-01133"]}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:sec>\n<jats:title>:<\/jats:title>\n<jats:p>Thymidine phosphorylase (TP), also referred to as \"platelet-derived endothelial\ncell growth factor\" is crucial to the pyrimidine salvage pathway. TP reversibly transforms\nthymidine into thymine and 2-deoxy-D-ribose-1-phosphate (dRib-1-P), which further degraded\nto 2-Deoxy-D-ribose (2DDR), which has both angiogenic and chemotactic activity.\nIn several types of human cancer such as breast and colorectal malignancies, TP is\nabundantly expressed in response to biological disturbances like hypoxia, acidosis, chemotherapy,\nand radiation therapy. TP overexpression is highly associated with angiogenic\nfactors such as vascular endothelial growth factor (VEGF), interleukins (ILs), matrix metalloproteases\n(MMPs), etc., which accelerate tumorigenesis, invasion, metastasis, immune\nresponse evasion, and resistant to apoptosis. Hence, TP is recognized as a key target for\nthe development of new anticancer drugs. Heterocycles are the primary structural element\nof most chemotherapeutics. Even 75% of nitrogen-containing heterocyclic compounds are\ncontributing to the pharmaceutical world. To create the bioactive molecule, medicinal\nchemists are concentrating on nitrogen-containing heterocyclic compounds such as pyrrole,\npyrrolidine, pyridine, imidazole, pyrimidines, pyrazole, indole, quinoline, oxadiazole,\nbenzimidazole, etc. The Oxadiazole motif stands out among all of them due to its\nenormous significance in medicinal chemistry. The main thrust area of this review is to\nexplore the synthesis, SAR, and the significant role of 1,3,4-oxadiazole derivatives as a\nTP inhibitor for their chemotherapeutic effects.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929867331666230712113943","type":"journal-article","created":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T04:50:29Z","timestamp":1689223829000},"page":"6227-6250","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["1,3,4-Oxadiazole: An Emerging Scaffold to Inhibit the Thymidine Phosphorylase as an Anticancer Agent"],"prefix":"10.2174","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8783-4275","authenticated-orcid":true,"given":"Anjali","family":"Murmu","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Guru Ghasidas Vishwavidyalaya (A Central University), Bilaspur, 495009, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8085-588X","authenticated-orcid":true,"given":"Purusottam","family":"Banjare","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Guru Ghasidas Vishwavidyalaya (A Central University), Bilaspur, 495009, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6147-5515","authenticated-orcid":true,"given":"Balaji Wamanrao","family":"Matore","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Guru Ghasidas Vishwavidyalaya (A Central University), Bilaspur, 495009, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2357-3234","authenticated-orcid":true,"given":"Partha Pratim","family":"Roy","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Guru Ghasidas Vishwavidyalaya (A Central University), Bilaspur, 495009, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6165-218X","authenticated-orcid":true,"given":"Jagadish","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Guru Ghasidas Vishwavidyalaya (A Central University), Bilaspur, 495009, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4137\/CGM.S11285","volume":"7","author":"Goubran H.A.","year":"2014","unstructured":"Goubran H.A.; Kotb R.R.; Stakiw J.; Emara M.E.; Burnouf T.; Regulation of tumor growth and metastasis: The role of tumor microenvironment. Cancer Growth Metastasis  2014,7,9-18","journal-title":"Cancer Growth Metastasis"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.canlet.2008.02.031","volume":"266","author":"Nishikawa M.","year":"2008","unstructured":"Nishikawa M.; Reactive oxygen species in tumor metastasis. Cancer Lett  2008,266(1),53-59","journal-title":"Cancer Lett"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"180625","DOI":"10.5888\/pcd16.180625","volume":"16","author":"Levine S.","year":"2019","unstructured":"Levine S.; Malone E.; Lekiachvili A.; Briss P.; Health care industry insights: Why the use of preventive services is still low. Prev Chronic Dis  2019,16(3),180625","journal-title":"Prev Chronic Dis"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"Siegel R.L.","year":"2023","unstructured":"Siegel R.L.; Miller K.D.; Wagle N.S.; Jemal A.; Cancer statistics, 2023. CA Cancer J Clin  2023,73(1),17-48","journal-title":"CA Cancer J Clin"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"108238","DOI":"10.1016\/j.jmgm.2022.108238","volume":"116","author":"Matore B.W.","year":"2022","unstructured":"Matore B.W.; Banjare P.; Singh J.; Roy P.P.; In silico selectivity modeling of pyridine and pyrimidine based CYP11B1 and CYP11B2 inhibitors: A case study. J Mol Graph Model  2022,116,108238","journal-title":"J Mol Graph Model"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.2174\/1568026616666160212122609","volume":"16","author":"Ahmad Ganai S.","year":"2016","unstructured":"Ahmad Ganai S.; Novel approaches towards designing of isoform-selective inhibitors against class II histone deacetylases: The acute requirement for targetted anticancer therapy. Curr Top Med Chem  2016,16(22),2441-2452","journal-title":"Curr Top Med Chem"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.2174\/1568026616666160927160620","volume":"17","author":"Oliveira Pedrosa M.","year":"2017","unstructured":"Oliveira Pedrosa M.; Duarte da Cruz R.; Oliveira Viana J.; de Moura R.; Ishiki H.; Barbosa Filho J.; Diniz M.; Scotti M.; Scotti L.; Bezerra Mendonca F.; Hybrid compounds as direct multitarget ligands: A review. Curr Top Med Chem  2017,17(9),1044-1079","journal-title":"Curr Top Med Chem"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"16852","DOI":"10.3390\/molecules200916852","volume":"20","author":"Martins P.","year":"2015","unstructured":"Martins P.; Jesus J.; Santos S.; Raposo L.; Roma-Rodrigues C.; Baptista P.; Fernandes A.; Heterocyclic anticancer compounds: Recent advances and the paradigm shift towards the use of nanomedicine\u2019s tool box. Molecules  2015,20(9),16852-16891","journal-title":"Molecules"},{"key":"ref=9","first-page":"66","volume":"18","author":"Pearce S.","year":"2017","unstructured":"Pearce S.; The importance of heterocyclic compounds in anti-cancer drug design. Drug Discov World  2017,18(2),66-70","journal-title":"Drug Discov World"},{"key":"ref=10","first-page":"2993","volume":"3","author":"Bala S.","year":"2010","unstructured":"Bala S.; Kamboj S.; Kumar A.; Heterocyclic 1, 3, 4-oxadiazole compounds with diverse biological activities: A comprehensive review. J Pharm Res  2010,3(12),2993-2997","journal-title":"J Pharm Res"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.biopha.2014.10.007","volume":"68","author":"Keri R.S.","year":"2014","unstructured":"Keri R.S.; Patil S.A.; Quinoline: A promising antitubercular target. Biomed Pharmacother  2014,68(8),1161-1175","journal-title":"Biomed Pharmacother"},{"key":"ref=12","first-page":"141","volume":"9","author":"Al-Mulla A.","year":"2017","unstructured":"Al-Mulla A.; A review: Biological importance of heterocyclic compounds. Der Pharma Chem  2017,9(13),141-147","journal-title":"Der Pharma Chem"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/07391102.2023.2178510","author":"Matore B.W.","year":"2023","unstructured":"Matore B.W.; Roy P.P.; Singh J.; Discovery of novel VEGFR2-TK inhibitors by phthalimide pharmacophore based virtual screening, molecular docking, MD simulation and DFT. J Biomol Struct Dyn  2023,1-22","journal-title":"J Biomol Struct Dyn"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"e202204851","DOI":"10.1002\/slct.202204851","volume":"8","author":"Matore B.W.","year":"2023","unstructured":"Matore B.W.; Banjare P.; Sarthi A.S.; Roy P.P.; Singh J.; Phthalimides represent a promising scaffold for multi-targeted anticancer agents. ChemistrySelect  2023,8(9),e202204851","journal-title":"ChemistrySelect"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.ejmech.2015.04.051","volume":"97","author":"Bajaj S.","year":"2015","unstructured":"Bajaj S.; Asati V.; Singh J.; Roy P.P.; 1,3,4-Oxadiazoles: An emerging scaffold to target growth factors, enzymes and kinases as anti-cancer agents. Eur J Med Chem  2015,97,124-141","journal-title":"Eur J Med Chem"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.3390\/molecules23123361","volume":"23","author":"Glomb T.","year":"2018","unstructured":"Glomb T.; Szymankiewicz K.; \u015awi\u0105tek P.; Anti-cancer activity of derivatives of 1,3,4-oxadiazole. Molecules  2018,23(12),3361","journal-title":"Molecules"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"8692","DOI":"10.3390\/ijms21228692","volume":"21","author":"Benassi A.","year":"2020","unstructured":"Benassi A.; Doria F.; Pirota V.; Groundbreaking anticancer activity of highly diversified oxadiazole scaffolds. Int J Mol Sci  2020,21(22),8692","journal-title":"Int J Mol Sci"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ejmech.2017.05.043","volume":"137","author":"Zhao S.","year":"2017","unstructured":"Zhao S.; Zhang X.; Wei P.; Su X.; Zhao L.; Wu M.; Hao C.; Liu C.; Zhao D.; Cheng M.; Design, synthesis and evaluation of aromatic heterocyclic derivatives as potent antifungal agents. Eur J Med Chem  2017,137,96-107","journal-title":"Eur J Med Chem"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"963","DOI":"10.3390\/molecules24050963","volume":"24","author":"Anouar E.H.","year":"2019","unstructured":"Anouar E.H.; Moustapha M.E.; Taha M.; Geesi M.H.; Farag Z.R.; Rahim F.; Almandil N.B.; Farooq R.K.; Nawaz M.; Mosaddik A.; Synthesis, molecular docking and \u03b2-glucuronidase inhibitory potential of indole base oxadiazole derivatives. Molecules  2019,24(5),963","journal-title":"Molecules"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"3014","DOI":"10.1016\/j.bmcl.2017.05.019","volume":"27","author":"Mente\u015fe E.","year":"2017","unstructured":"Mente\u015fe E.; Bekta\u015f H.; Sokmen B.B.; Emirik M.; \u00c7ak\u0131r D.; Kahveci B.; Synthesis and molecular docking study of some 5,6-dichloro-2-cyclopropyl-1 H-benzimidazole derivatives bearing triazole, oxadiazole, and imine functionalities as potent inhibitors of urease. Bioorg Med Chem Lett  2017,27(13),3014-3018","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.mib.2016.05.009","volume":"33","author":"Janardhanan J.","year":"2016","unstructured":"Janardhanan J.; Chang M.; Mobashery S.; The oxadiazole antibacterials. Curr Opin Microbiol  2016,33,13-17","journal-title":"Curr Opin Microbiol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"9122","DOI":"10.3390\/ijms21239122","volume":"21","author":"Glomb T.","year":"2020","unstructured":"Glomb T.; Wiatrak B.; G\u0119bczak K.; G\u0119barowski T.; Bodetko D.; Czy\u017cnikowska \u017b.; \u015awi\u0105tek P.; New 1,3,4-oxadiazole derivatives of pyridothiazine-1,1-dioxide with anti-inflammatory activity. Int J Mol Sci  2020,21(23),9122","journal-title":"Int J Mol Sci"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.bioorg.2018.01.007","volume":"77","author":"Verma G.","year":"2018","unstructured":"Verma G.; Chashoo G.; Ali A.; Khan M.F.; Akhtar W.; Ali I.; Akhtar M.; Alam M.M.; Shaquiquzzaman M.; Synthesis of pyrazole acrylic acid based oxadiazole and amide derivatives as antimalarial and anticancer agents. Bioorg Chem  2018,77,106-124","journal-title":"Bioorg Chem"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.bioorg.2018.01.040","volume":"77","author":"Tantray M.A.","year":"2018","unstructured":"Tantray M.A.; Khan I.; Hamid H.; Alam M.S.; Dhulap A.; Kalam A.; Synthesis of benzimidazole-linked-1,3,4-oxadiazole carboxamides as GSK-3\u03b2 inhibitors with in vivo antidepressant activity. Bioorg Chem  2018,77,393-401","journal-title":"Bioorg Chem"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1016\/j.bmcl.2015.03.032","volume":"25","author":"Yadagiri B.","year":"2015","unstructured":"Yadagiri B.; Gurrala S.; Bantu R.; Nagarapu L.; Polepalli S.; Srujana G.; Jain N.; Synthesis and evaluation of benzosuberone embedded with 1,3,4-oxadiazole, 1,3,4-thiadiazole and 1,2,4-triazole moieties as new potential anti proliferative agents. Bioorg Med Chem Lett  2015,25(10),2220-2224","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s13075-022-02818-6","volume":"24","author":"Stern E.P.","year":"2022","unstructured":"Stern E.P.; Host L.V.; Wanjiku I.; Escott K.J.; Gilmour P.S.; Ochiel R.; Unwin R.; Burns A.; Ong V.H.; Cadiou H.; O\u2019Keeffe A.G.; Denton C.P.; Zibotentan in systemic sclerosis-associated chronic kidney disease: A phase II randomised placebo-controlled trial. Arthritis Res Ther  2022,24(1),130","journal-title":"Arthritis Res Ther"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13065-020-00721-2","volume":"14","author":"Siwach A.","year":"2020","unstructured":"Siwach A.; Verma P.K.; Therapeutic potential of oxadiazole or furadiazole containing compounds. BMC Chem  2020,14(1),70","journal-title":"BMC Chem"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"100058","DOI":"10.1016\/j.ejmcr.2022.100058","volume":"5","author":"Matore B.W.","year":"2022","unstructured":"Matore B.W.; Banjare P.; Guria T.; Roy P.P.; Singh J.; Oxadiazole derivatives: Histone deacetylase inhibitors in anticancer therapy and drug discovery. Eur J Med Chem Rep  2022,5(March),100058","journal-title":"Eur J Med Chem Rep"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3390\/ph14050438","volume":"14","author":"Stecoza C.E.","year":"2021","unstructured":"Stecoza C.E.; Nitulescu G.M.; Draghici C.; Caproiu M.T.; Olaru O.T.; Bostan M.; Mihaila M.; Synthesis and anticancer evaluation of new 1,3,4-oxadiazole derivatives. Pharmaceuticals  2021,14(5),438","journal-title":"Pharmaceuticals"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s12307-015-0173-y","volume":"9","author":"Elamin Y.Y.","year":"2016","unstructured":"Elamin Y.Y.; Rafee S.; Osman N.; O Byrne K.J.; Gately K.; Thymidine phosphorylase in cancer; Enemy or friend? Cancer Microenviron  2016,9(1),33-43","journal-title":"Cancer Microenviron"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.compbiolchem.2018.05.013","volume":"76","author":"Bajaj S.","year":"2018","unstructured":"Bajaj S.; Roy P.P.; Singh J.; Synthesis, thymidine phosphorylase inhibitory and computational study of novel 1,3,4-oxadiazole-2-thione derivatives as potential anticancer agents. Comput Biol Chem  2018,76,151-160","journal-title":"Comput Biol Chem"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"104873","DOI":"10.1016\/j.bioorg.2021.104873","volume":"111","author":"Bajaj S.","year":"2021","unstructured":"Bajaj S.; Kumar M.S.; Tinwala H.; Yc M.; Design, synthesis, modelling studies and biological evaluation of 1,3,4-oxadiazole derivatives as potent anticancer agents targeting thymidine phosphorylase enzyme. Bioorg Chem  2021,111(111),104873","journal-title":"Bioorg Chem"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"4098","DOI":"10.1016\/S0021-9258(18)61316-X","volume":"262","author":"Miyazono K.","year":"1987","unstructured":"Miyazono K.; Okabe T.; Urabe A.; Takaku F.; Heldin C.H.; Purification and properties of an endothelial cell growth factor from human platelets. J Biol Chem  1987,262(9),4098-4103","journal-title":"J Biol Chem"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0021-9258(18)71264-7","volume":"207","author":"Friedkin M.","year":"1954","unstructured":"Friedkin M.; Roberts D.; The enzymatic synthesis of nucleosides. I. thymidine phosphorylase in mammalian tissue. J Biol Chem  1954,207(1),245-256","journal-title":"J Biol Chem"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.trecan.2022.01.018","volume":"8","author":"Warfield B.M.","year":"2022","unstructured":"Warfield B.M.; Reigan P.; Multifunctional role of thymidine phosphorylase in cancer. Trends Cancer  2022,8(6),482-493","journal-title":"Trends Cancer"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1107\/S1399004714001904","volume":"70","author":"Timofeev V.","year":"2014","unstructured":"Timofeev V.; Abramchik Y.; Zhukhlistova N.; Muravieva T.; Fateev I.; Esipov R.; Kuranova I.; 3\u2032-Azidothymidine in the active site of Escherichia coli thymidine phosphorylase: The peculiarity of the binding on the basis of X-ray study. Acta Crystallogr D Biol Crystallogr  2014,70(4),1155-1165","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.tcm.2017.10.003","volume":"28","author":"Li W.","year":"2018","unstructured":"Li W.; Yue H.; Thymidine phosphorylase: A potential new target for treating cardiovascular disease. Trends Cardiovasc Med  2018,28(3),157-171","journal-title":"Trends Cardiovasc Med"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1002\/pro.5560010514","volume":"1","author":"Barton G.J.","year":"1992","unstructured":"Barton G.J.; Ponting C.P.; Spraggon G.; Finnis C.; Sleep D.; Human platelet-derived endothelial cell growth factor is homologous to Escherichia coli thymidine phosphorylase. Protein Sci  1992,1(5),688-690","journal-title":"Protein Sci"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/path.1711760212","volume":"176","author":"Fox S.B.","year":"1995","unstructured":"Fox S.B.; Moghaddam A.; Westwood M.; Turley H.; Bicknell R.; Gatter K.C.; Harris A.L.; Platelet-derived endothelial cell growth factor\/thymidine phosphorylase expression in normal tissues: An immunohistochemical study. J Pathol  1995,176(2),183-190","journal-title":"J Pathol"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1081\/NCN-200027702","volume":"23","author":"de Bruin M.","year":"2004","unstructured":"de Bruin M.; van Capel T.; Smid K.; van der Born K.; Fukushima M.; Hoekman K.; Pinedo H.M.; Peters G.J.; Role of platelet derived endothelial cell growth factor\/thymidine phosphorylase in fluoropyrimidine sensitivity and potential role of deoxyribose-1-phosphate. Nucleosides Nucleotides Nucleic Acids  2004,23(8-9),1485-1490","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"4156","DOI":"10.3390\/ma14154156","volume":"14","author":"Zag\u00f3rska A.","year":"2021","unstructured":"Zag\u00f3rska A.; Czopek A.; Jaromin A.; Mielczarek-Puta M.; Struga M.; Stary D.; Bajda M.; Design, synthesis, and in vitro antiproliferative activity of hydantoin and purine derivatives with the 4-acetylphenylpiperazinylalkyl moiety. Materials  2021,14(15),4156","journal-title":"Materials"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.fertnstert.2004.02.135","volume":"82","author":"Abbas M.M.","year":"2004","unstructured":"Abbas M.M.; Evans J.J.; Sykes P.H.; Benny P.S.; Modulation of vascular endothelial growth factor and thymidine phosphorylase in normal human endometrial stromal cells. Fertil Steril  2004,82(S 3),1048-1053","journal-title":"Fertil Steril"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1210\/jc.85.1.402","volume":"85","author":"Sharkey A.M.","year":"2000","unstructured":"Sharkey A.M.; Day K.; McPherson A.; Malik S.; Licence D.; Smith S.K.; Charnock-Jones D.S.; Vascular endothelial growth factor expression in human endometrium is regulated by hypoxia. J Clin Endocrinol Metab  2000,85(1),402-409","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"368","DOI":"10.3389\/fvets.2019.00368","volume":"6","author":"Zizzo N.","year":"2019","unstructured":"Zizzo N.; Passantino G.; D\u2019alessio R.M.; Tinelli A.; Lopresti G.; Patruno R.; Tricarico D.; Maqoud F.; Scala R.; Zito F.A.; Ranieri G.; Thymidine phosphorylase expression and microvascular density correlation analysis in canine mammary tumor: Possible prognostic factor in breast cancer. Front Vet Sci  2019,6,368","journal-title":"Front Vet Sci"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0027-5107(88)90074-7","volume":"200","author":"Shaw T.","year":"1988","unstructured":"Shaw T.; Smillie R.H.; MacPhee D.G.; The role of blood platelets in nucleoside metabolism: Assay, cellular location and significance of thymidine phosphorylase in human blood. Mutat Res  1988,200(1-2),99-116","journal-title":"Mutat Res"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.bcp.2010.05.009","volume":"80","author":"Bijnsdorp I.V.","year":"2010","unstructured":"Bijnsdorp I.V.; Azijli K.; Jansen E.E.; Wamelink M.M.; Jakobs C.; Struys E.A.; Fukushima M.; Kruyt F.A.E.; Peters G.J.; Accumulation of thymidine-derived sugars in thymidine phosphorylase overexpressing cells. Biochem Pharmacol  2010,80(6),786-792","journal-title":"Biochem Pharmacol"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1016\/j.bcp.2007.05.008","volume":"74","author":"Liekens S.","year":"2007","unstructured":"Liekens S.; Bronckaers A.; P\u00e9rez-P\u00e9rez M.J.; Balzarini J.; Targeting platelet-derived endothelial cell growth factor\/thymidine phosphorylase for cancer therapy. Biochem Pharmacol  2007,74(11),1555-1567","journal-title":"Biochem Pharmacol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/ijc.11315","volume":"106","author":"Sato J.","year":"2003","unstructured":"Sato J.; Sata M.; Nakamura H.; Inoue S.; Wada T.; Takabatake N.; Otake K.; Tomoike H.; Kubota I.; Role of thymidine phosphorylase on invasiveness and metastasis in lung adenocarcinoma. Int J Cancer  2003,106(6),863-870","journal-title":"Int J Cancer"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1039\/D0RA10263F","volume":"11","author":"Tarar A.","year":"2021","unstructured":"Tarar A.; Alyami E.M.; Peng C.A.; Mesenchymal stem cells anchored with thymidine phosphorylase for doxifluridine-mediated cancer therapy. RSC Advances  2021,11(3),1394-1403","journal-title":"RSC Advances"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.bioorg.2018.02.028","volume":"78","author":"Taha M.","year":"2018","unstructured":"Taha M.; Adnan Ali Shah S.; Afifi M.; Imran S.; Sultan S.; Rahim F.; Hadiani Ismail N.; Mohammed Khan K.; Synthesis, molecular docking study and thymidine phosphorylase inhibitory activity of 3-formylcoumarin derivatives. Bioorg Chem  2018,78,17-23","journal-title":"Bioorg Chem"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"116","DOI":"10.2174\/978160805162511101010116","author":"Nencka R.","year":"2011","unstructured":"Nencka R.; Thymidine phosphorylase inhibitors. Anti-Angiogenesis Drug Discovery and Development  2011,116-147","journal-title":"Anti-Angiogenesis Drug Discovery and Development"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1002\/art.1780370509","volume":"37","author":"Takeuchi M.","year":"1994","unstructured":"Takeuchi M.; Otsuka T.; Matsui N.; Asai K.; Hirano T.; Moriyama A.; Isobe I.; Eksioglu Y.Z.; Matsukawa K.; Kato T.; Tada T.; Aberrant production of gliostatin\/platelet-derived endothelial cell growth factor in rheumatoid synovium. Arthritis Rheum  1994,37(5),662-672","journal-title":"Arthritis Rheum"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"653773","DOI":"10.3389\/fmed.2021.653773","volume":"8","author":"Li W.","year":"2021","unstructured":"Li W.; Yue H.; Thymidine phosphorylase is increased in COVID-19 patients in an acuity-dependent manner. Front Med  2021,8,653773","journal-title":"Front Med"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"466","DOI":"10.5530\/pj.2019.11.73","volume":"11","author":"Jacob J.","year":"2019","unstructured":"Jacob J.; R, G.; P, L.; Illuri, R.; Bhosle, D.; Sangli, G.K.; Mundkinajeddu, D. Evaluation of anti-psoriatic potential of the fruit rind of Punica granatum L. Pharmacogn J  2019,11(3),466-468","journal-title":"Pharmacogn J"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1023\/A:1024515517623","volume":"5","author":"Creamer D.","year":"2002","unstructured":"Creamer D.; Sullivan D.; Bicknell R.; Barker J.; Angiogenesis in psoriasis. Angiogenesis  2002,5(4),231-236","journal-title":"Angiogenesis"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12876-018-0925-5","volume":"19","author":"Patel R.","year":"2019","unstructured":"Patel R.; Coulter L.L.; Rimmer J.; Parkes M.; Chinnery P.F.; Swift O.; Mitochondrial neurogastrointestinal encephalopathy: A clinicopathological mimic of Crohn\u2019s disease. BMC Gastroenterol  2019,19(1),11","journal-title":"BMC Gastroenterol"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/S0006-291X(05)80025-7","volume":"184","author":"Usuki K.","year":"1992","unstructured":"Usuki K.; Saras J.; Waltenberger J.; Miyazono K.; Pierce G.; Thomason A.; Heldin C.H.; Platelet-derived endothelial cell growth factor has thymidine phosphorylase activity. Biochem Biophys Res Commun  1992,184(3),1311-1316","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1002\/art.38263","volume":"66","author":"Toyoda Y.","year":"2014","unstructured":"Toyoda Y.; Tabata S.; Kishi J.; Kuramoto T.; Mitsuhashi A.; Saijo A.; Kawano H.; Goto H.; Aono Y.; Hanibuchi M.; Horikawa H.; Nakajima T.; Furukawa T.; Sone S.; Akiyama S.; Nishioka Y.; Thymidine phosphorylase regulates the expression of CXCL10 in rheumatoid arthritis fibroblast-like synoviocytes. Arthritis Rheumatol  2014,66(3),560-568","journal-title":"Arthritis Rheumatol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3389\/fncel.2017.00031","volume":"11","author":"Yadak R.","year":"2017","unstructured":"Yadak R.; Sillevis Smitt P.; van Gisbergen M.W.; van Til N.P.; de Coo I.F.M.; Mitochondrial neurogastrointestinal encephalomyopathy caused by thymidine phosphorylase enzyme deficiency: From pathogenesis to emerging therapeutic options. Front Cell Neurosci  2017,11(February),31","journal-title":"Front Cell Neurosci"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13023-019-1016-6","volume":"14","author":"Yadak R.","year":"2019","unstructured":"Yadak R.; Breur M.; Bugiani M.; Gastrointestinal dysmotility in MNGIE: From thymidine phosphorylase enzyme deficiency to altered interstitial cells of Cajal. Orphanet J Rare Dis  2019,14(1),33","journal-title":"Orphanet J Rare Dis"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"110352","DOI":"10.1016\/j.ecoenv.2020.110352","volume":"193","author":"Yang L.","year":"2020","unstructured":"Yang L.; Wang Y.; Hao W.; Chang J.; Pan Y.; Li J.; Wang H.; Modeling pesticides toxicity to Sheepshead minnow using QSAR. Ecotoxicol Environ Saf  2020,193(February),110352","journal-title":"Ecotoxicol Environ Saf"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1093\/jnci\/58.6.1587","volume":"58","author":"Pauly J.L.","year":"1977","unstructured":"Pauly J.L.; Schuller M.G.; Zelcer A.A.; Kirss T.A.; Gore S.S.; Germain M.J.; Identification and comparative analysis of thymidine phosphorylase in the plasma of healthy subjects and cancer patients. J Natl Cancer Inst  1977,58(6),1587-1590","journal-title":"J Natl Cancer Inst"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.bmcl.2015.12.041","volume":"26","author":"Leemans E.","year":"2016","unstructured":"Leemans E.; Mahasenan K.V.; Kumarasiri M.; Spink E.; Ding D.; O\u2019Daniel P.I.; Boudreau M.A.; Lastochkin E.; Testero S.A.; Yamaguchi T.; Lee M.; Hesek D.; Fisher J.F.; Chang M.; Mobashery S.; Three-dimensional QSAR analysis and design of new 1,2,4-oxadiazole antibacterials. Bioorg Med Chem Lett  2016,26(3),1011-1015","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"911","DOI":"10.2147\/OTT.S71089","volume":"8","author":"Mihalcioiu C.","year":"2015","unstructured":"Mihalcioiu C.; Tedeschi A.L.; Eslami Z.; Saleh R.; Omeroglu A.; Gulbeyaz A.; Ait-Tihyaty M.; Jean-Claude B.; Garoufalis E.; Pilot study investigating the prognostic significance of thymidine phosphorylase expression in patients with metastatic breast cancer: A single institution retrospective analysis. OncoTargets Ther  2015,8,911-919","journal-title":"OncoTargets Ther"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1159\/000133191","volume":"59","author":"Stenman G.","year":"1992","unstructured":"Stenman G.; Sahlin P.; Dumanski J.P.; Hagiwara K.; Ishikawa F.; Miyazono K.; Collins V.P.; Heldin C.H.; Regional localization of the human platelet-derived endothelial cell growth factor (ECGF1) gene to chromosome 22q13. Cytogenet Genome Res  1992,59(1),22-23","journal-title":"Cytogenet Genome Res"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"14016","DOI":"10.1016\/S0021-9258(18)77450-4","volume":"265","author":"Walter M.R.","year":"1990","unstructured":"Walter M.R.; Cook W.J.; Cole L.B.; Short S.A.; Koszalka G.W.; Krenitsky T.A.; Ealick S.E.; Three-dimensional structure of thymidine phosphorylase from Escherichia coli at 2.8 A resolution. J Biol Chem  1990,265(23),14016-14022","journal-title":"J Biol Chem"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1006\/jmbi.1998.1941","volume":"281","author":"Pugmire M.J.","year":"1998","unstructured":"Pugmire M.J.; Cook W.J.; Jasanoff A.; Walter M.R.; Ealick S.E.; Structural and theoretical studies suggest domain movement produces an active conformation of thymidine phosphorylase. J Mol Biol  1998,281(2),285-299","journal-title":"J Mol Biol"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.str.2003.11.018","volume":"12","author":"Norman R.A.","year":"2004","unstructured":"Norman R.A.; Barry S.T.; Bate M.; Breed J.; Colls J.G.; Ernill R.J.; Luke R.W.A.; Minshull C.A.; McAlister M.S.B.; McCall E.J.; McMiken H.H.J.; Paterson D.S.; Timms D.; Tucker J.A.; Pauptit R.A.; Crystal structure of human thymidine phosphorylase in complex with a small molecule inhibitor. Structure  2004,12(1),75-84","journal-title":"Structure"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1042\/BJ20060513","volume":"399","author":"Omari K.E.L.","year":"2006","unstructured":"Omari K.E.L.; Bronckaers A.; Liekens S.; P\u00e9rez-P\u00e9rez M.J.; Balzarini J.; Stammers D.K.; Structural basis for non-competitive product inhibition in human thymidine phosphorylase: Implications for drug design. Biochem J  2006,399(2),199-204","journal-title":"Biochem J"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.bbrc.2009.06.104","volume":"386","author":"Mitsiki E.","year":"2009","unstructured":"Mitsiki E.; Papageorgiou A.C.; Iyer S.; Thiyagarajan N.; Prior S.H.; Sleep D.; Finnis C.; Acharya K.R.; Structures of native human thymidine phosphorylase and in complex with 5-iodouracil. Biochem Biophys Res Commun  2009,386(4),666-670","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1002\/med.20159","volume":"29","author":"Bronckaers A.","year":"2009","unstructured":"Bronckaers A.; Gago F.; Balzarini J.; Liekens S.; The dual role of thymidine phosphorylase in cancer development and chemotherapy. Med Res Rev  2009,29(6),903-953","journal-title":"Med Res Rev"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/bj3340001","volume":"334","author":"Brown N.S.","year":"1998","unstructured":"Brown N.S.; Bicknell R.; Thymidine phosphorylase, 2-deoxy-D-ribose and angiogenesis. Biochem J  1998,334(1),1-8","journal-title":"Biochem J"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S0021-9258(18)76947-0","volume":"85","author":"Levene P.A.","year":"1930","unstructured":"Levene P.A.; Mikeska L.A.; Mori T.; Carbohydrate of thymonucleic acid. J Biol Chem  1930,85(3),785-787","journal-title":"J Biol Chem"},{"key":"ref=74","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1006\/gyno.1998.5122","volume":"72","author":"Sakamoto H.","year":"1999","unstructured":"Sakamoto H.; Shirakawa T.; Izuka S.; Igarashi T.; Kinoshita K.; Ohtani K.; Takami T.; Thymidine phosphorylase expression is predominantly observed in stroma of well-differentiated adenocarcinoma of endometrium and correlates with a frequency of vascular involvement. Gynecol Oncol  1999,72(3),298-305","journal-title":"Gynecol Oncol"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/bjc.2011.74","volume":"104","author":"Bijnsdorp I.V.","year":"2011","unstructured":"Bijnsdorp I.V.; Capriotti F.; Kruyt F A E.; Losekoot N.; Fukushima M.; Griffioen A.W.; Thijssen V.L.; Peters G.J.; Thymidine phosphorylase in cancer cells stimulates human endothelial cell migration and invasion by the secretion of angiogenic factors. Br J Cancer  2011,104(7),1185-1192","journal-title":"Br J Cancer"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"11437","DOI":"10.3390\/ijms222111437","volume":"22","author":"Dikici S.","year":"2021","unstructured":"Dikici S.; Yar M.; Bullock A.J.; Shepherd J.; Roman S.; Macneil S.; Developing wound dressings using 2-Deoxy-D -ribose to induce angiogenesis as a backdoor route for stimulating the production of vascular endothelial growth factor. Int J Mol Sci  2021,22(21),11437","journal-title":"Int J Mol Sci"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/S1470-2045(05)01766-3","volume":"6","author":"Toi M.","year":"2005","unstructured":"Toi M.; Rahman M.A.; Bando H.; Chow L.W.C.; Thymidine phosphorylase (platelet-derived endothelial-cell growth factor) in cancer biology and treatment. Lancet Oncol  2005,6(3),158-166","journal-title":"Lancet Oncol"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.molmed.2007.08.001","volume":"13","author":"Chiang G.G.","year":"2007","unstructured":"Chiang G.G.; Abraham R.T.; Targeting the mTOR signaling network in cancer. Trends Mol Med  2007,13(10),433-442","journal-title":"Trends Mol Med"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1016\/S0002-9440(10)65475-2","volume":"155","author":"Konda R.","year":"1999","unstructured":"Konda R.; Sato H.; Sakai K.; Sato M.; Orikasa S.; Kimura N.; Expression of platelet-derived endothelial cell growth factor and its potential role in up-regulation of angiogenesis in scarred kidneys secondary to urinary tract diseases. Am J Pathol  1999,155(5),1587-1597","journal-title":"Am J Pathol"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/path.2174","volume":"212","author":"Gunningham S.P.","year":"2007","unstructured":"Gunningham S.P.; Currie M.J.; Morrin H.R.; Tan E.Y.; Turley H.; Dachs G.U.; Watson A.I.; Frampton C.; Robinson B.A.; Fox S.B.; The angiogenic factor thymidine phosphorylase up-regulates the cell adhesion molecule P-selectin in human vascular endothelial cells and is associated with P-selectin expression in breast cancers. J Pathol  2007,212(3),335-344","journal-title":"J Pathol"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/sj.bjp.0705216","volume":"139","author":"Sengupta S.","year":"2003","unstructured":"Sengupta S.; Sellers L.A.; Matheson H.B.; Fan T.P.D.; Thymidine phosphorylase induces angiogenesis in vivo and in vitro: An evaluation of possible mechanisms. Br J Pharmacol  2003,139(2),219-231","journal-title":"Br J Pharmacol"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1093\/annonc\/mdn592","volume":"20","author":"Andreetta C.","year":"2009","unstructured":"Andreetta C.; Puppin C.; Minisini A.; Valent F.; Pegolo E.; Damante G.; Di Loreto C.; Pizzolitto S.; Pandolfi M.; Fasola G.; Piga A.; Puglisi F.; Thymidine phosphorylase expression and benefit from capecitabine in patients with advanced breast cancer. Ann Oncol  2009,20(2),265-271","journal-title":"Ann Oncol"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.3390\/molecules13081897","volume":"13","author":"Koukourakis G.","year":"2008","unstructured":"Koukourakis G.; Kouloulias V.; Koukourakis M.; Zacharias G.; Zabatis H.; Kouvaris J.; Efficacy of the oral fluorouracil pro-drug capecitabine in cancer treatment: A review. Molecules  2008,13(8),1897-1922","journal-title":"Molecules"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"5568","DOI":"10.3390\/jcm10235568","volume":"10","author":"Voutsadakis I.A.","year":"2021","unstructured":"Voutsadakis I.A.; biomarkers of trifluridine-tipiracil efficacy. J Clin Med  2021,10(23),5568","journal-title":"J Clin Med"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.clcc.2017.01.003","volume":"16","author":"Lee J.J.","year":"2017","unstructured":"Lee J.J.; Chu E.; Adherence, dosing, and managing toxicities with trifluridine\/tipiracil (TAS-102). Clin Colorectal Cancer  2017,16(2),85-92","journal-title":"Clin Colorectal Cancer"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/S0046-8177(97)90252-5","volume":"28","author":"Doussis-Anagnostopoulou I.A.","year":"1997","unstructured":"Doussis-Anagnostopoulou I.A.; Remadi S.; Turley H.; Gindre P.; Comley M.; Borisch B.; Gatter K.C.; Platelet-derived endothelial cell growth factor\/thymidine phosphorylase immunohistochemical expression in lymphoid tissue and lymphoid malignancies. Hum Pathol  1997,28(10),1146-1151","journal-title":"Hum Pathol"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1038\/sj.bjc.6600281","volume":"86","author":"Sivridis E.","year":"2002","unstructured":"Sivridis E.; Giatromanolaki A.; Papadopoulos I.; Gatter K.C.; Harris A.L.; Koukourakis M.I.; Thymidine phosphorylase expression in normal, hyperplastic and neoplastic prostates: Correlation with tumour associated macrophages, infiltrating lymphocytes, and angiogenesis. Br J Cancer  2002,86(9),1465-1471","journal-title":"Br J Cancer"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3748\/wjg.v10.i4.545","volume":"10","author":"Zhang J.M.","year":"2004","unstructured":"Zhang J.M.; Mizoi T.; Shiiba K.; Sasaki I.; Matsuno S.; Expression of thymidine phosphorylase by macrophages in colorectal cancer tissues. World J Gastroenterol  2004,10(4),545-549","journal-title":"World J Gastroenterol"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1111\/j.1349-7006.2004.tb02193.x.","volume":"95","author":"Akiyama S.","year":"2004","unstructured":"Akiyama S.; Furukawa T.; Sumizawa T.; Takebayashi Y.; Nakajima Y.; Haraguchi M.; The role of thymidine phosphorylase, an angiogenic enzyme, in tumor progression. Cancer Sci  2004,95(11),851-857","journal-title":"Cancer Sci"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2174\/187152009787313846","volume":"9","author":"Nakajima Y.","year":"2009","unstructured":"Nakajima Y.; Madhyastha R.; Maruyama M.; 2-Deoxy-D-ribose, a downstream mediator of thymidine phosphorylase, regulates tumor angiogenesis and progression. Anticancer Agents Med Chem  2009,9(2),239-245","journal-title":"Anticancer Agents Med Chem"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"10473","DOI":"10.18632\/oncotarget.2242","volume":"5","author":"Tabata S.","year":"2014","unstructured":"Tabata S.; Ikeda R.; Yamamoto M.; Shimaoka S.; Mukaida N.; Takeda Y.; Yamada K.; Soga T.; Furukawa T.; Akiyama S.; Thymidine phosphorylase activates NF\u03baB and stimulates the expression of angiogenic and metastatic factors in human cancer cells. Oncotarget  2014,5(21),10473-10485","journal-title":"Oncotarget"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"100633","DOI":"10.1016\/j.esmoop.2022.100633","volume":"7","author":"Van Cutsem E.","year":"2022","unstructured":"Van Cutsem E.; Hochster H.; Shitara K.; Mayer R.; Ohtsu A.; Falcone A.; Yoshino T.; Doi T.; Ilson D.H.; Arkenau H.T.; George B.; Benhadji K.A.; Makris L.; Tabernero J.; Pooled safety analysis from phase III studies of trifluridine\/tipiracil in patients with metastatic gastric or gastroesophageal junction cancer and metastatic colorectal cancer. ESMO Open  2022,7(6),100633","journal-title":"ESMO Open"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1007\/s10120-021-01156-x","volume":"24","author":"Mansoor W.","year":"2021","unstructured":"Mansoor W.; Arkenau H.T.; Alsina M.; Shitara K.; Thuss-Patience P.; Cuffe S.; Dvorkin M.; Park D.; Ando T.; Van Den Eynde M.; Beretta G.D.; Zaniboni A.; Doi T.; Tabernero J.; Ilson D.H.; Makris L.; Benhadji K.A.; Van Cutsem E.; Trifluridine\/tipiracil in patients with metastatic gastroesophageal junction cancer: A subgroup analysis from the phase 3 TAGS study. Gastric Cancer  2021,24(4),970-977","journal-title":"Gastric Cancer"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12885-022-10489-4","volume":"23","author":"Taieb J.","year":"2023","unstructured":"Taieb J.; Price T.; Vidot L.; Chevallier B.; Wyrwicz L.; Bachet J.B.; Safety and efficacy of trifluridine\/tipiracil in previously treated metastatic colorectal cancer: Final results from the phase IIIb single-arm PRECONNECT study by duration of therapy. BMC Cancer  2023,23(1),94","journal-title":"BMC Cancer"},{"key":"ref=95","first-page":"97","volume":"9Spec Feature","author":"Raedler B.L.A.","year":"2016","unstructured":"Raedler B.L.A.; Lonsurf (trifluridine plus tipiracil): A new oral treatment approved for patients with metastatic colorectal cancer. Am Health Drug Benefits  2016,9Spec Feature,97-100","journal-title":"Am Health Drug Benefits"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.1016\/j.bmc.2004.04.046","volume":"12","author":"Yano S.","year":"2004","unstructured":"Yano S.; Kazuno H.; Sato T.; Suzuki N.; Emura T.; Wierzba K.; Yamashita J.; Tada Y.; Yamada Y.; Fukushima M.; Asao T.; Synthesis and evaluation of 6-methylene-bridged uracil derivatives. Part 2: Optimization of inhibitors of human thymidine phosphorylase and their selectivity with uridine phosphorylase. Bioorg Med Chem  2004,12(13),3443-3450","journal-title":"Bioorg Med Chem"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1038\/sj.bjc.6600808","volume":"88","author":"Bruin M.","year":"2003","unstructured":"Bruin M.; De; Capel, T.; Van; Born, K.; Van Der; Kruyt, F. A.; Fukushima, M.; Hoekman, K.; Pinedo, H. M. Role of platelet-derived endothelial cell growth factor\/thymidine phosphorylase in fluoropyrimidine sensitivity. Br J Cancer  2003,88,957-964","journal-title":"Br J Cancer"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"3705","DOI":"10.1016\/j.bmcl.2003.08.010","volume":"13","author":"McNally V.A.","year":"2003","unstructured":"McNally V.A.; Gbaj A.; Douglas K.T.; Stratford I.J.; Jaffar M.; Freeman S.; Bryce R.A.; Identification of a novel class of inhibitor of human and Escherichia coli thymidine phosphorylase by in silico screening. Bioorg Med Chem Lett  2003,13(21),3705-3709","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.ejmech.2016.10.032","volume":"124","author":"Bera H.","year":"2016","unstructured":"Bera H.; Chigurupati S.; Recent discovery of non-nucleobase thymidine phosphorylase inhibitors targeting cancer. Eur J Med Chem  2016,124,992-1003","journal-title":"Eur J Med Chem"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"5562","DOI":"10.1021\/jm0605379","volume":"49","author":"Casanova E.","year":"2006","unstructured":"Casanova E.; Herna A.; 5\u2032-O-Tritylinosine and analogues as allosteric inhibitors of human thymidine phosphorylase. J Med Chem  2006,49(18),5562-5570","journal-title":"J Med Chem"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"e0225056","DOI":"10.1371\/journal.pone.0225056","volume":"14","author":"Javaid S.","year":"2019","unstructured":"Javaid S.; Shaikh M.; Fatima N.; Choudhary M.I.; Natural compounds as angiogenic enzyme thymidine phosphorylase inhibitors: In vitro biochemical inhibition, mechanistic, and in silico modeling studies. PLoS One  2019,14(11),e0225056","journal-title":"PLoS One"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.bioorg.2015.10.006","volume":"63","author":"Javaid S.","year":"2015","unstructured":"Javaid S.; Saad S.M.; Perveen S.; Khan K.M.; Choudhary M.I.; 2-Arylquinazolin-4(3H)-ones: A novel class of thymidine phosphorylase inhibitors. Bioorg Chem  2015,63,142-151","journal-title":"Bioorg Chem"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.bioorg.2019.01.005","volume":"85","author":"Shahzad S.A.","year":"2019","unstructured":"Shahzad S.A.; Yar M.; Khan Z.A.; Shahzadi L.; Naqvi S.A.R.; Mahmood A.; Ullah S.; Shaikh A.J.; Sherazi T.A.; Bale A.T.; Kuku\u0142owicz J.; Bajda M.; Identification of 1,2,4-triazoles as new thymidine phosphorylase inhibitors: Future anti-tumor drugs. Bioorg Chem  2019,85(85),209-220","journal-title":"Bioorg Chem"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"103876","DOI":"10.1016\/j.bioorg.2020.103876","volume":"100","author":"Shahzad S.A.","year":"2020","unstructured":"Shahzad S.A.; Sarfraz A.; Yar M.; Khan Z.A.; Naqvi S.A.R.; Naz S.; Khan N.A.; Farooq U.; Batool R.; Ali M.; Synthesis, evaluation of thymidine phosphorylase and angiogenic inhibitory potential of ciprofloxacin analogues: Repositioning of ciprofloxacin from antibiotic to future anticancer drugs. Bioorg Chem  2020,100(February),103876","journal-title":"Bioorg Chem"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"6010","DOI":"10.1007\/s00044-013-0589-1","volume":"22","author":"Bera H.","year":"2013","unstructured":"Bera H.; Sayan W.C.; Gupta D.; Synthesis, in vitro evaluation of thymidine phosphorylase inhibitory activity, and in silico study of 1,3,5-triazin-2,4-dione and its fused analogues. Med Chem Res  2013,22,6010-6021","journal-title":"Med Chem Res"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"5120","DOI":"10.1007\/s00044-014-1064-3","volume":"23","author":"Bensaber S.M.","year":"2015","unstructured":"Bensaber S.M.; Nouri H.A.A.; Salah B.E.; Zetrini A.A.; Alsabri S.G.; Erhuma M.; Hermann A.; Jaeda M.I.; Gbaj A.M.; Chemical synthesis, molecular modelling, and evaluation of anticancer activity of some pyrazol-3-one Schiff base derivatives. Med Chem Res  2015,23,5120-5134","journal-title":"Med Chem Res"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"44247","DOI":"10.1039\/D0RA09198G","volume":"2020","author":"Heravi M.M.","year":"2020","unstructured":"Heravi M.M.; Zadsirjan V.; Prescribed drugs containing nitrogen heterocycles: An overview. RSC Advances  2020,2020(72),44247-44311","journal-title":"RSC Advances"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.1007\/s00253-022-11969-0","volume":"106","author":"Atmaram U.A.","year":"2022","unstructured":"Atmaram U.A.; Roopan S.M.; Roopan M.; Biological activity of oxadiazole and thiadiazole derivatives. Appl Microbiol Biotechnol  2022,106(9-10),3489-3505","journal-title":"Appl Microbiol Biotechnol"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.1016\/j.ejmech.2011.03.031","volume":"46","author":"Kumar D.","year":"2011","unstructured":"Kumar D.; Patel G.; Chavers A.K.; Chang K.H.; Shah K.; Synthesis of novel 1,2,4-oxadiazoles and analogues as potential anticancer agents. Eur J Med Chem  2011,46(7),3085-3092","journal-title":"Eur J Med Chem"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.3390\/molecules26041163","volume":"26","author":"Banik B.K.","year":"2021","unstructured":"Banik B.K.; Sahoo B.M.; Kumar B.V.V.R.; Panda K.C.; Jena J.; Mahapatra M.K.; Borah P.; Green synthetic approach: An efficient eco-friendly tool for synthesis of biologically active oxadiazole derivatives. Molecules  2021,26(4),1163","journal-title":"Molecules"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1021\/jm2013248","volume":"55","author":"Bostr\u00f6m J.","year":"2012","unstructured":"Bostr\u00f6m J.; Hogner A.; Llin\u00e0s A.; Wellner E.; Plowright A.T.; Oxadiazoles in medicinal chemistry. J Med Chem  2012,55(5),1817-1830","journal-title":"J Med Chem"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10406638.2021.1886123","volume":"0","author":"Kapoor G.","year":"2021","unstructured":"Kapoor G.; Bhutani R.; Pathak D.P.; Chauhan G.; Grover P.; Nagarajan K.; Siddiqui S.A.; Current advancement in the oxadiazole-based scaffolds as anticancer agents current advancement in the oxadiazole-based scaffolds as anticancer agents. Polycycl Aromat Compd  2021,0(0),1-33","journal-title":"Polycycl Aromat Compd"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ardp.201300231","volume":"347","author":"Khan I.","year":"2013","unstructured":"Khan I.; Ibrar A.; Abbas N.; Review article oxadiazoles as privileged motifs for promising anticancer leads: Recent advances and future prospects. Arch Pharm  2013,347(1),1-20","journal-title":"Arch Pharm"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3906\/kim-1602-79","volume":"41","author":"Sajid M.A.","year":"2017","unstructured":"Sajid M.A.; Khan Z.A.; Shahzad S.A.; Naqvi S.A.R.; Usman M.; Iqbal A.; Recent advances in thymidine phosphorylase inhibitors: Syntheses and prospective medicinal applications. Turk J Chem  2017,41,1-28","journal-title":"Turk J Chem"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"e1003226","DOI":"10.1371\/journal.pcbi.1003226","volume":"9","author":"Tang J.","year":"2013","unstructured":"Tang J.; Karhinen L.; Xu T.; Szwajda A.; Yadav B.; Wennerberg K.; Aittokallio T.; Target inhibition networks: Predicting selective combinations of druggable targets to block cancer survival pathways. PLOS Comput Biol  2013,9(9),e1003226","journal-title":"PLOS Comput Biol"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"101284","DOI":"10.1016\/j.jscs.2021.101284","volume":"25","author":"Nayak S.","year":"2021","unstructured":"Nayak S.; Gaonkar S.L.; Musad E.A.; Dawsar A.M.A.L.; Dawsar A.L.; 1,3,4-Oxadiazole-containing hybrids as potential anticancer agents: Recent developments, mechanism of action and structure-activity relationships. J Saudi Chem Soc  2021,25(8),101284","journal-title":"J Saudi Chem Soc"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"86","DOI":"10.30574\/wjarr.2021.9.1.0472","volume":"9","author":"Tiwari D.","year":"2021","unstructured":"Tiwari D.; Narang R.; Lal S.; A review on microwave assisted synthesis, mechanism of action and structure activity relationship of 1,3,4-oxadiazole derivatives as anticancer agent. World J Adv Res Rev  2021,9(1),86-96","journal-title":"World J Adv Res Rev"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.2174\/138955705774933301","volume":"5","author":"Priego E.","year":"2005","unstructured":"Priego E.; Hern\u00e1ndez A.; Camarasa M.; Balzarini J.; Liekens S.; thymidine phosphorylase inhibitors: Recent developments and potential therapeutic applications. Mini Rev Med Chem  2005,5(12),1113-23","journal-title":"Mini Rev Med Chem"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"5136","DOI":"10.1158\/1078-0432.CCR-08-3203","volume":"15","author":"Lu H.","year":"2009","unstructured":"Lu H.; Klein R.S.; Schwartz E.L.; Antiangiogenic and antitumor activity of 6-(2-aminoethyl)amino-5-chlorouracil, a novel small-molecule inhibitor of thymidine phosphorylase, in combination with the vascular endothelial growth factor-trap. Clin Cancer Res  2009,15(16),5136-5144","journal-title":"Clin Cancer Res"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.3390\/molecules24061002","volume":"24","author":"Almandil N.B.","year":"2019","unstructured":"Almandil N.B.; Taha M.; Farooq R.K.; Alhibshi A.; Ibrahim M.; Anouar E.H.; Gollapalli M.; Rahim F.; Nawaz M.; Adnan S.; Synthesis of thymidine phosphorylase inhibitor based on quinoxaline derivatives and their molecular docking study. Molecules  2019,24(6),1002","journal-title":"Molecules"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/j.bmc.2013.12.043","volume":"22","author":"Shahzad S.A.","year":"2014","unstructured":"Shahzad S.A.; Yar M.; Bajda M.; Jadoon B.; Khan Z.A.; Naqvi S.A.R.; Shaikh A.J.; Hayat K.; Mahmmod A.; Mahmood N.; Filipek S.; Synthesis and biological evaluation of novel oxadiazole derivatives: A new class of thymidine phosphorylase inhibitors as potential anti-tumor agents. Bioorg Med Chem  2014,22(3),1008-1015","journal-title":"Bioorg Med Chem"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.bioorg.2018.05.026","volume":"80","author":"Iftikhar F.","year":"2018","unstructured":"Iftikhar F.; Yaqoob F.; Tabassum N.; Jan M.S.; Sadiq A.; Tahir S.; Batool T.; Niaz B.; Ansari F.L.; Choudhary M.I.; Rashid U.; Design, synthesis, in-vitro thymidine phosphorylase inhibition, in-vivo antiangiogenic and in-silico studies of C-6 substituted dihydropyrimidines. Bioorg Chem  2018,80(April),99-111","journal-title":"Bioorg Chem"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"6022","DOI":"10.1007\/s00044-013-0588-2","volume":"22","author":"Khan K.M.","year":"2013","unstructured":"Khan K.M.; Rani M.; Ambreen N.; Ali M.; Hussain S.; Perveen S.; Choudhary M.I.; 2,5-Disubstituted-1,3,4-oxadiazoles: Thymidine phosphorylase inhibitors. Med Chem Res  2013,22(12),6022-6028","journal-title":"Med Chem Res"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejmech.2019.02.033","volume":"168","author":"Lakshmithendral K.","year":"2019","unstructured":"Lakshmithendral K.; Saravanan K.; Elancheran R.; Archana K.; Manikandan N.; Arjun H.A.; Ramanathan M.; Lokanath N.K.; Kabilan S.; Design, synthesis and biological evaluation of 2-(phenoxymethyl)-5-phenyl-1,3,4-oxadiazole derivatives as anti-breast cancer agents. Eur J Med Chem  2019,168,1-10","journal-title":"Eur J Med Chem"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.bioorg.2015.04.003","volume":"60","author":"Shahzad S.A.","year":"2015","unstructured":"Shahzad S.A.; Yar M.; Bajda M.; Shahzadi L.; Khan Z.A.; Naqvi S.A.R.; Mutahir S.; Mahmood N.; Khan K.M.; Synthesis, thymidine phosphorylase inhibition and molecular modeling studies of 1,3,4-oxadiazole-2-thione derivatives. Bioorg Chem  2015,60,37-41","journal-title":"Bioorg Chem"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.bioorg.2018.05.011","volume":"79","author":"Javid M.T.","year":"2018","unstructured":"Javid M.T.; Rahim F.; Taha M.; Nawaz M.; Wadood A.; Ali M.; Mosaddik A.; Shah S.A.A.; Farooq R.K.; Synthesis, SAR elucidations and molecular docking study of newly designed isatin based oxadiazole analogs as potent inhibitors of thymidine phosphorylase. Bioorg Chem  2018,79(February),323-333","journal-title":"Bioorg Chem"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"3654","DOI":"10.1016\/j.bmc.2018.05.046","volume":"26","author":"Taha M.","year":"2018","unstructured":"Taha M.; Rashid U.; Imran S.; Ali M.; Rational design of bis-indolylmethane-oxadiazole hybrids as inhibitors of thymidine phosphorylase. Bioorg Med Chem  2018,26(12),3654-3663","journal-title":"Bioorg Med Chem"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1134\/S1070428021120150","volume":"57","author":"Ullah H.","year":"2021","unstructured":"Ullah H.; Khan F.; Taha M.; Rahim F.; Sarfraz M.; Aziz A.; Ullah S.; Khan M.U.; Ullah M.; New thiazole-bearing oxadiazole derivatives: Synthesis, thymidine phosphorylase inhibitory potential, and molecular docking study. Russ J Org Chem  2021,57(12),1993-2001","journal-title":"Russ J Org Chem"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.bioorg.2018.02.020","volume":"78","author":"Ullah H.","year":"2018","unstructured":"Ullah H.; Rahim F.; Taha M.; Uddin I.; Wadood A.; Shah S.A.A.; Farooq R.K.; Nawaz M.; Wahab Z.; Khan K.M.; Synthesis, molecular docking study and in vitro thymidine phosphorylase inhibitory potential of oxadiazole derivatives. Bioorg Chem  2018,78,58-67","journal-title":"Bioorg Chem"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"16015","DOI":"10.1038\/s41598-019-52100-0","volume":"9","author":"Zaman K.","year":"2019","unstructured":"Zaman K.; Rahim F.; Taha M.; Wadood A.; Shah S.A.A.; Ahmed Q.U.; Zakaria Z.A.; Synthesis of new isoquinoline-base-oxadiazole derivatives as potent inhibitors of thymidine phosphorylase and molecular docking study. Sci Rep  2019,9(1),16015","journal-title":"Sci Rep"},{"key":"ref=131","volume":"8","author":"El-mernissi R.","year":"2020","unstructured":"El-mernissi R.; El K.; Aanouz I.; Ghaleb A.; Khaldan A.; 2D-QSAR studies of isatin based oxadiazole analogs as potent inhibitors of thymidine phosphorylase. RHAZES: Green Appl Chem  2020,8","journal-title":"RHAZES: Green Appl Chem"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"e21046","DOI":"10.1016\/S1872-2040(21)60095-6","volume":"49","author":"Jian-bo T.","year":"2021","unstructured":"Jian-bo T.; Yi F.; Tian-hao W.; Ding L.U.O.; Investigation of quantitative structure activity relationship of isatin-based oxadiazole derivatives as thymidine phosphorylase inhibitors. Chin J Anal Chem  2021,49(4),e21046-e21054","journal-title":"Chin J Anal Chem"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.2174\/1871520620666200705214917","volume":"20","author":"Lang D.K.","year":"2020","unstructured":"Lang D.K.; Kaur R.; Arora R.; Saini B.; Arora S.; Nitrogen-containing heterocycles as anticancer agents: An overview. Anticancer Agents Med Chem  2020,20(18),2150-2168","journal-title":"Anticancer Agents Med Chem"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"988071","DOI":"10.3389\/fimmu.2022.988071","volume":"13","author":"Paladhi A.","year":"2022","unstructured":"Paladhi A.; Daripa S.; Mondal I.; Hira S.K.; Targeting thymidine phosphorylase alleviates resistance to dendritic cell immunotherapy in colorectal cancer and promotes antitumor immunity. Front Immunol  2022,13,988071","journal-title":"Front Immunol"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1016\/j.biocel.2006.04.007","volume":"38","author":"Temmink O.H.","year":"2006","unstructured":"Temmink O.H.; de Bruin M.; Laan A.C.; Turksma A.W.; Cricca S.; Masterson A.J.; Noordhuis P.; Peters G.J.; The role of thymidine phosphorylase and uridine phosphorylase in (fluoro)pyrimidine metabolism in peripheral blood mononuclear cells. Int J Biochem Cell Biol  2006,38(10),1759-1765","journal-title":"Int J Biochem Cell Biol"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867331666230712113943","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/218665\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867331666230712113943","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T10:13:15Z","timestamp":1732183995000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/218665\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":135,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867331666230712113943","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-02-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-03","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}